Noel Aineplan's research while affiliated with National Drug Authority - Uganda and other places

Publications (3)

Article
Full-text available
Background Haemovigilance is an important element of blood regulation. It includes collecting and evaluating the information on adverse events resulting from the use of blood and blood components with the aim to improve donor and patient safety. We describe the results of the pilot of the integrated GBT+ Blood for the haemovigilance function in 10...
Preprint
Full-text available
Background: Haemovigilance is an important element of blood regulation. It includes collecting and evaluating information on adverse events resulting from the use of blood and blood components with the aim to improve donor and patient safety. We assessed how haemovigilance is currently being implemented and performed in 10 sub-Saharan African count...
Article
Full-text available
Access to essential medicines is a key pillar of any health system seeking to deliver universal health coverage. Science-based, independent regulation of medical products is a critical part of ensuring that only quality essential medicines reach the patients who need them. • In this article, we explore the progress the East African Community's Medi...

Citations

... As a result, the true objective of a Hv is to increase blood transfusion efficiency. As these are widely accredited across all the analytical procedures that assured the quality of blood and its components regarding the improvement of health to save the patient's life during acute emergencies [14][15][16]. Figure 1 is showing the organogram of Hv. Hv is considered to be a developing field in medical science that helps in blood transfusion as its introduction is currently considered to be an integral part of blood safety across the world [17]. ...
... With the launch of the EAC-MRH programme, the EAC authorities have made substantial progress in reducing timelines for registration of medical products using the joint review process. A study of the EAC-MRH pilot phase (2012-2017) by Mashingia and colleagues found that registration timelines were reduced from 24 months to 8-12 months for products reviewed using this process (Mashingia et al., 2020). ...